Investing Profile

Jens Eckstein

VCInvestor
Managing Partner at Apollo Health Ventures
apollo.vc/team/jens-ecksteinCambridge, Massachusetts
Photo of Jens Eckstein, Managing Partner at Apollo Health Ventures
Your Intro Paths to Jens Eckstein

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Jens is a member of
Harvard University Network
793 CONNECTIONS
Alex & Thiago Network
499 CONNECTIONS
Alex & Thiago Network
499 CONNECTIONS
Alex & Thiago Network
499 CONNECTIONS
Alex & Thiago Network
499 CONNECTIONS

Find Jens Eckstein on

cb
Current Investing Position
Apollo Health Ventures Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$2.5M
Investments On Record
23

Jens Eckstein is on these Sector & Stage Rankings

Jens Eckstein's Investments On Record (12)

CompanyStageDateRound SizeTotal Raised
Aeovian Pharmaceuticals
Series BDec 2025$55M
Series AOct 2019$37M
$140M
Co-investors: Richard Gaster (venBio Partners), Themasap Khan (Luma Group), William Greene (MPM BioImpact), Viktoriya Tigipko (TA Ventures)
HAYA Therapeutics
Series AMay 2025$65M
SeedFeb 2022$5M
SeedMay 2021$20M
$90M
Co-investors: Benjamin Kreitman (Broadview Ventures Inc), Sebastian Bernales (Humboldt Fund), Henrijette Richter (Sofinnova Partners)
Vandria
Series AAug 2024$10M
$31M
Co-investors: Dani Bach (+ND Capital)
Ochre Bio
SeedJun 2021$10M
$40M
Co-investors: Alex Morgan (Khosla Ventures), Chris Gibson (6 Dimensions Capital), Aniq Kassam (Stealth Capital), Milad Alucozai (Entrepreneur First), Rob Kniaz (Hoxton Ventures), Alice Zhang
Decibel Therapeutics
Series CJun 2018$55M
Series AOct 2015$52M
$190M
Co-investors: Anthony Philippakis (GV (Google Ventures)), Krishna Yeshwant (GV (Google Ventures)), Peter Thompson (OrbiMed)
Palleon Pharmaceuticals
Series AOct 2017$48M
$48M
ZappRx
Series BApr 2017$25M
Series AApr 2015$14M
SeedJan 2014$1M
$41M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Wayne Chang (Techstars), Mark McDade (Qiming Venture Partners USA), Hakan Satiroglu (BrightLoop Learning)
Gladius Pharmaceuticals
Series AJun 2015$3M
$3M

Jens Eckstein's Experience

Non-Executive Director Imugene LimitedPresent
Advisor, Member Board of Directors Cleara Biotech B.V.Present
Member Board of Directors, Chairman of the Board Aeovian PharmaceuticalsPresent
Board Observer Ochre BioPresent
Chairman Booster TherapeuticsPresent
Chairman Refoxy PharmaPresent
Member Board Of Directors, Interim Chairman HAYA TherapeuticsPresent
Advisor Alex & ThiagoPresent
Member Board of Directors, President Alex & ThiagoPresent
Member of the Board of Advisors Apollo Health VenturesPresent
Advisor Booster TherapeuticsPresent
President Alex & ThiagoPresent
Advisor Refoxy PharmaPresent
Member Board of Directors Vandria SAPresent
President and Founder Alex & ThiagoPresent
Partner TVM Capital Life SciencePresent
General Partner TVM Capital Life SciencePresent
CEO and President SelectX PharmaceuticalsPresent
Venture Partner and Entrepreneur-in-Residence TVM Capital Life SciencePresent
Founder, Director & Managing Partner Action Potential Venture CapitalPresent
Co-Founder, Director Palleon PharmaceuticalsPresent
Co-Founder, Director Decibel TherapeuticsPresent
President and Chairman of the Board, Interim CEO Samsara TherapeuticsPresent
Managing Partner Apollo Health VenturesPresent
Investment Partner Hevolution FoundationPresent

Jens Eckstein's Education

Universität Konstanz Diplom Chemistry
University of Konstanz Diplom Chemistry
University of Konstanz Ph.D. Biological Chemistry
Universität Konstanz Ph.D. Biological Chemistry
Harvard University Visiting Scholar Biological Chemistry
University of California, San Francisco Postdoctoral Fellow Enzyme Mechanisms and Drug Design

Investors who invest with Jens Eckstein

Sign in with Google →

Scouts & Angels Affiliated With Jens Eckstein

Sign in with Google →